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S U M M A R Y
Objectives: The aim of this study was to determine the demographic, clinical, and notiﬁcation data of
suspected dengue fever (DF) and dengue hemorrhagic fever (DHF) cases admitted to Jaffna Teaching
Hospital, Sri Lanka.
Methods: The data were collected from bed head tickets of all patients presenting with clinically
suspected DF/DHF from October 2009 to September 2010.
Results: A total of 1085 clinically suspected DF/DHF cases were identiﬁed, with high numbers occurring
during December 2009 to March 2010. The majority of the reported patients were females (n = 550,
50.7%) and approximately three-quarters of the patients (n = 797, 73.5%) were adults. All had fever, but
fever spikes were noted in only 129 cases (11.9%; 95% conﬁdence interval (CI) 10.1–13.9%). Over 50% of
cases had vomiting (95% CI 47.5–53.5%). Haemorrhages were noted in 266 (24.5%), with gum bleeding in
99 patients (37.2%). Low white blood cell and platelet counts were noted in 27.1% and 85.6% of cases,
respectively. Of the 1085 cases, only 24 (2.2%) were screened for dengue IgM/IgG and only 458 cases
(42.2%) were notiﬁed to the Epidemiology Unit, Ministry of Health, Sri Lanka.
Conclusions: The absence of laboratory diagnosis and poor notiﬁcation to the Epidemiology Unit were
the major drawbacks noted.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Dengue virus (DENV) infection has been affecting humans for
many years, with an estimated 50 million DENV infections
occurring every year globally. On average, one million dengue
fever (DF) and dengue hemorrhagic fever (DHF) cases have been* Corresponding author. Tel.: +94 81 2396532; fax: +94 81 2389106.
E-mail addresses: faseehan@pdn.ac.lk, faseeha.noordeen12@gmail.com
(F. Noordeen).
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1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).reported annually in more than 100 countries in the tropical and
subtropical regions of the world.1 Dengue cases across the dengue
endemic regions including the Americas, Southeast Asia, and the
Western Paciﬁc exceeded 1.2 million in 2008 and 2.3 million in
2010 based on ofﬁcial data submitted by the member states. Over
the last 2 to 3 years, overall reported cases of dengue have
continued to increase at an alarming rate, and there has been an
expansion of the endemic regions.2 Moreover, the spread of Aedes
species mosquitoes and their adaptation to a changing climate,
population growth, unplanned urbanization, evolving dengue
viruses, and the lack of laboratory diagnostic facilities in severalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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increase in dengue cases, but have also caused difﬁculties in
managing the cases in those countries effectively.3,4
DF/DHF is a mosquito-borne Flavivirus infection. DENV-infected
individuals experience a spectrum of clinical manifestations,
which include an acute self-limiting ﬂu-like illness to a severe
disease with haemoconcentration (20% increase in haematocrit)
and evidence of plasma leakage, such as pleural effusion and
ascites; the latter is termed DHF. Clinically DF is mid-way between
mild DENV infection and DHF and is characterized by headache,
myalgia, arthralgia, retro-orbital pain, and occasionally a macu-
lopapular rash. In some patients, DHF might progress to
hypovolemic shock and this is termed dengue shock syndrome
(DSS).
DF/DHF is an increasingly important public health problem in
Sri Lanka. Unlike malaria, which is prevalent in the agrarian
suburban areas of the island, DF/DHF is prevalent mostly in the
urban areas of cities. The four serotypes of DENV have been co-
circulating in Sri Lanka for more than 30 years and their
distribution has not changed drastically, despite the emergence
of new subtypes within a serotype.3 Although the Sri Lankan
population had been exposed to DENV for a long time, severe
forms of DENV infection (DHF/DSS) were rare before 1989.5
Studies have shown the existence of more than one DENV
serotype in many parts of the country,3 but the status of the
different DENV serotypes and their presence in the Northern
Province is not known, as the area was affected by war and was
unsettled for more than 30 years. There was a report of an island-
wide epidemic of DF associated with DENV serotypes 1 and
2 from 1965 to 1968 that caused DHF in 66 patients and
15 deaths.6 Serotypes DENV-1 and DENV-2 were isolated from
the outbreaks in 1965 and 19667 and the Northern Province was
not affected by this epidemic.
Data from a study conducted between 2003 and 2006 indicated
the circulation of DENV-1 serotype in the Western Province of Sri
Lanka.8 In 2009, Sri Lanka experienced the largest epidemic of DF/
DHF (35 008 reported cases and 346 deaths; 170 cases/
100 000 population); a study conducted in Colombo determined
the cause of this outbreak to be a new strain of DENV-1.9 However
further investigations are necessary to determine the dynamics of
the DENV DF/DHF outbreak of 2009 in the North Province of Sri
Lanka. DENV nucleic acid detection by RT-PCR in patients with
DF/DHF from August 2010 to December 2010 showed the
predominance of DENV-1, accounting for more than 95% of cases

















Figure 1. Notiﬁcation of clinically suspected DF/DHF cases from Jaffna District,
2006–2010.to that observed by the Epidemiology Unit of the country for the
stated period, suggesting a serotype shift in the larger DF/DHF
outbreaks in the last 2–3 years in Sri Lanka.
In general, over 1000 DF/DHF cases have been reported in Sri
Lanka every year, mostly from the South, West, and Central
provinces of the island. However, with the cessation of the 30-year
conﬂict in the Northern Province, there has been a rapid increase
in DF/DHF cases in the North (capital Jaffna) starting from
the bigger island-wide outbreak in 2009 (Figure 1). Although a
lot has been done to understand the circulating types of DENV in
resource-limited areas like the Northern Province, we conducted
this study to determine certain aspects of the epidemiology and
clinical features of clinically suspected DF/DHF in patients
admitted to Jaffna Teaching Hospital (JTH). We also sought to
assess the accuracy of the case notiﬁcation process to the
Epidemiology Unit of the Ministry of Health, Sri Lanka.
2. Materials and methods
2.1. Study setting
Ethical clearance for the study was obtained from the Faculty of
Medicine, University of Peradeniya, Sri Lanka. This was a
retrospective study that analyzed the available data from JTH,
which is the largest leading state hospital governed by the Central
Government of Sri Lanka and is the only teaching hospital in the
Northern Province of Sri Lanka. Altogether 2767 patients were
admitted with a clinical diagnosis of DF/DHF between October
2009 and September 2010. However, complete data were
available for only 1085 patients.
Data were extracted from patient notes to collect socio-
demographic factors, clinical characteristics of the presenting
illness, laboratory investigations, probable diagnosis, manage-
ment, and the outcome of the illness. If not indicated in the
individual case notes, certain signs and symptoms of DF/DHF were
considered to be absent in that particular patient. The white blood
cell count (WBC), platelet count, haemoglobin (Hb), packed cell
volume (PCV), blood urea (BU), sodium, potassium, and dengue
IgM/IgG were obtained from the laboratory reports. If reports
were not available for a particular parameter, we assumed that the
patient was not investigated for that parameter.
2.2. Notiﬁcation data
Notiﬁcation information for the patients with DF/DHF was
obtained from the notiﬁcation register maintained by the infection
control unit of the hospital.
2.3. Data analysis
Data were analyzed using SPSS version 17 (SPSS Inc., Chicago, IL,
USA); the Chi-square test and Fisher’s exact test were used to
explain associations. Odd ratios (OR) were used wherever
applicable, and p-values of <0.05 were considered signiﬁcant.
3. Results
A total of 1085 DF/DHF cases (with complete records) were
identiﬁed for the period October 2009 to September 2010. A
seasonal association was observed, with the highest number of DF/
DHF cases occurring during January 2010. Five hundred and ﬁfty
(50.7%) of the reported cases were females. There were signiﬁ-
cantly more adult suspected DF/DHF cases than child cases
(n = 797, 73.5%; p < 0.001). Although all patients with DF/DHF had
fever, fever spikes were noted on admission in only 129 cases
(11.9%; 95% conﬁdence interval (CI) 10.1–13.9%). On average, fever
Table 1
Summary of clinical and laboratory proﬁles of adult DF/DHF cases in the current and previous studies
Symptoms Present study Kularatne et al.13 Malavige et al.16
Area: Northern 95% CI Area: Central Area: Western
Number studied 797 348 108
Headache (%) 60.8 57.4–64.2 74.8 NS
Vomiting (%) 50.6 47.1–54.0 NS 64
Myalgia (%) 30.9 27.7–34.1 73.2 76
Flushing (%) 29.9 26.8–33.1 35 42
Bleeding manifestations (%) 28.1 25.1–31.3 6.8 42
Arthralgia (%) 14.6 12.2–17.1 NS 57
Retro-orbital pain (%) 9.9 8.0–12.1 NS NS
Ascites/pleural effusions (%) 12.2 9.2–15.1 3 45
Hepatomegaly (%) 19.9 17.3–22.8 NS 0.02
DF, dengue fever; DHF, dengue haemorrhagic fever; CI, conﬁdence interval; NS, not stated.
Table 2
Summary of clinical and laboratory proﬁles of child DF/DHF cases in the current and
previous studies
Symptoms Present study Malavige et al.19
Area: Northern 95% CI Area: Western
Number studied 288 108
Headache (%) 35 29.7–40.7 NS
Vomiting (%) 48.9 43.2–54.7 64
Myalgia (%) 13.8 10.2–18.3 76
Flushing (%) 13.8 10.2–18.3 42
Bleeding manifestations (%) 15.2 11.5–19.8 42
Arthralgia (%) 5.2 3.1–8.3 57
Fever spike (%) 11.9 8.4–15.9 NS
Retro-orbital pain (%) 2.4 1.1–4.7 NS
Ascites (%) 2.8 1.3–5.2 45
Pleural effusions (%) 3.8 2.0–6.5 66.3
Hepatomegaly (%) 43.7 38.1–49.5 0.02
WBC <4  109/l 21.5 17.1–26.6 15.3
Prolonged CRT 8.3 5.5–12.0 29.8
Platelets <100  109/l 88.5 84.5–91.8 70.1
DF, dengue fever; DHF, dengue haemorrhagic fever; CI, conﬁdence interval; NS, not
stated; WBC, white blood cell count; CRT, capillary reﬁlling time.
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cases were admitted to hospital 8 days after the onset of symptoms
(mean 7.93, median 8, range 1–24 days). The youngest case
was aged 1 year and the oldest was aged 83 years; the mean age
was 22.1 years. Clinicians in the Northern Province categorized
suspected DF/DHF cases into three categories as follows: (1) DF, (2)
DHF, and (3) DENV infection. In that respect, 601 patients were
diagnosed with DF, 132 with DHF, and 352 patients were
diagnosed with a DENV infection; the latter was considered mild
compared to DF and DHF.
In the adult cohort, headache (60.8%), vomiting (50.6%), myalgia
(30.9%), and a ﬂushed appearance (29.9%) were the main clinical
features. Similar clinical features such as vomiting (49.8%),
headache (35%), myalgia (13.8%), and a ﬂushed appearance
(13.8%) were noted in children. Overall 266 (24.5%) patients had
haemorrhages, of whom 224 were adults. Hepatomegaly was more
common in children (43.7%) than adults (19.9%) (Tables 1 and 2). In
both age categories (children and adults, n = 266), gum bleeding
(37.2%) was the major haemorrhagic manifestation, followed by
melena, petechiae/purpura, haematemesis, and haemoptysis.
A low WBC (<4  109) and platelet count were noted in 294
(27.1%) and 929 (85.6%) patients, respectively. Approximately 7%
of the patients had a platelet count of <20  109/L. A prolonged
capillary reﬁlling time (CRT) was noted in 11.7% of the patients.
Hypotension and tachycardia were noted in 19% and 27.1%,
respectively. Of the 1085 suspected DF/DHF cases, only 24 (2.2%)
were screened for dengue IgM/IgG antibodies. Of these, 13 were
positive for dengue IgM only, ﬁve patients had both dengue IgMand IgG, and four only had dengue IgG. Of the 1085 DF/DHF cases
based on the complete records, only 458 (42.2%) were notiﬁed to
the Epidemiology Unit.
4. Discussion
Before 2009, DF/DHF was not a major public health problem in
Jaffna District and around 50 cases per year were notiﬁed to the
Epidemiology Unit of The Ministry of Health, Sri Lanka. However,
the Western, Southern, Central, and North Central provinces of
Sri Lanka have had high numbers of reported DF/DHF cases with
high morbidity and mortality since the late 1980s.
From 2008 to 2010, there was a sudden increase in DF/DHF
cases in Jaffna District (Figure 1). The numbers of reported DF/DHF
cases in 2008, 2009, and 2010 were 58, 422, and 2648, respectively.
Due to the unsettled conditions that prevailed in the Northern
Province of Sri Lanka until 2009, there was no movement of
people from other parts of the island to the North Province and vice
versa. With the complete opening of the major entry route to Jaffna
in 2009, after the end of war, there was a sudden movement of
people in both directions, but the rate of movement has been
highest from other parts of the island to Jaffna. It appears that
the movement of people has contributed to the signiﬁcantly higher
number of DF/DHF cases following the cessation of war.
Although Aedes species mosquitoes have been reported in Jaffna
for a long time, only a few cases of DF/DHF were reported until
2009. This might be due to the absence or low level of circulation of
DENV in Jaffna prior to the mass movement of people to the
peninsula following the end of conﬂict, despite the presence of
Aedes species mosquitoes. The establishment and spread of DENV
infections with the movement of people is a well documented
phenomenon in the expansion of DF/DHF in many regions of the
world.4,11 In the study area, poor reporting might have contributed
to the low number of cases until 2008 (n = 50). However, the
increase of >2000 cases in 2009/2010 cannot be explained by
delays in reporting. Conversely, even if we consider only the 458
(42.2% of the admitted cases with complete reports) cases reported
to the Epidemiology Unit of the Ministry of Health, this number is
still much higher than those reported prior to 2009.
Considering the inﬂuence of torrential rainfall patterns in the
area, a high number of DF/DHF cases (n = 809, 74.6%) were reported
between December 2009 and March 2010 (Figure 2), coinciding
with the monsoon rains in Jaffna District (Figure 2). Rainfall in
Jaffna occurs mainly from October to November by inter-
monsoonal rain and then from October to February by North East
monsoonal rain (Meteorology Department, Jaffna) and thus the
outbreak coincided with the inter-monsoonal and North East
monsoonal rains; this would have facilitated a conducive
environment for mosquito breeding and DENV transmission and



















Figure 2. Seasonal variation and the distribution of clinically suspected DF/DHF
cases.
K. Murugananthan et al. / International Journal of Infectious Diseases 27 (2014) 32–36 35coinciding with the torrential rainfall pattern has been shown in
India and the Philippines.12,13
Based on the demographic data, females were found to be
affected by DF/DHF slightly more than males in the adult and
paediatric cohorts, but this difference was not statistically
signiﬁcant (p > 0.5). Similar ﬁndings have been reported in
the Philippines13 and Sri Lanka;14 females have been shown to be
affected more than males. In contrast, other previous studies have
shown a higher prevalence of DF/DHF in males in India,12
Singapore,15 and certain areas of Sri Lanka.15,16 Nevertheless,
the ﬁnding of the current study of more females being affected
with DF/DHF than males was not statistically signiﬁcant and is not
consistent with some previous studies conducted in Sri Lanka. In
the study area, most adult females engage in outdoor activities
such as cleaning the house premises, gardening, and collecting
ﬁrewood from adjacent areas, hence these women may be exposed
to daytime biting mosquitoes.
The mean age of dengue-affected cases in this study was
22.1 years; this ﬁnding of adults being affected by DF/DHF is in
agreement with the data obtained from recent Sri Lankan studies.
In the past DF/DHF was primarily a paediatric disease in Sri Lanka,
however there has been a shift in the affected age in the last 8 years
(mean 22–25 years).3,14,16 Adults of both genders, either going to
ofﬁce jobs or working in the house premises or paddy ﬁelds might
be exposed to daytime biting mosquitoes. In contrast to adults,
infants mainly stay inside the houses during the daytime and thus
are protected from these mosquitoes. The staff of schools in Jaffna
District are well educated in taking measures to prevent dengue
mosquito breeding, hence the school children rarely acquire the
infection during the daytime. These reasons might explain the
higher number of cases among adults than children in the study
area. On the other hand adults may have immunity to a particular
type of DENV and these adults when infected with a second type of
DENV would become symptomatic, in contrast to children with
primary infections, again contributing to the increase in DF/DHF
cases in adults.
Based on the current study in adults (n = 797), fever and
headache were the predominant clinical features, followed by
vomiting, myalgia, haemorrhages, and a ﬂushed appearance
(Table 1). A similar clinical proﬁle has been reported in patients
from the Central Province of Sri Lanka in a small group of patients
(n = 348).14 On the other hand, myalgia, vomiting, arthralgia, and a
ﬂushed appearance have been reported among DF/DHF patients in
the Western Province; however these patients did not haveheadache but did have diarrhoea.17 The current study population
and the cohort of a previous study14 did not have diarrhoea as a
clinical manifestation, although diarrhoea has been observed in
patients in Singapore and Taiwan.18,19 The presence of diarrhoea
in certain study cohorts and its absence in other study cohorts
might be due to inter-observer variations and a lack of consistency
in self-reported morbidities by certain patients.
In paediatric patients, vomiting, headache, myalgia, and a
ﬂushed appearance were the common clinical manifestations in
the current study; these have been noted with high frequencies in a
different study20 (Table 2). In another study, headache and
myalgia/arthralgia were not noted in children;16 this might be
due to difﬁculties in expressing certain complaints by children in
certain populations. In the present study cohort, pleural effusions
and ascites were not common in children, but high frequencies of
pleural effusions and ascites have been noted in a previous study.20
In the current study, hepatomegaly was found in 26.5% (n = 287)
of patients – 43.7% of children and 19.9% of adults. Hepatomegaly
has been reported to be common in adults17 and absent in
children20 in previous studies; however hepatomegaly was absent
in both children and adults in one previous study.14 Inter-observer
variation might be one of the reasons for these discrepancies in the
clinical ﬁndings. Moreover, the immune status of the affected
population to dengue viruses and the genetic makeup of the
infecting dengue virus might also have had an inﬂuence on the
variation in clinical manifestations.
Although bleeding manifestations were high in adults, gum
bleeding was the most common in both children and adults,
followed by melena, petechiae/purpura, haematemesis, and
haemoptysis. In previous studies, the petechiae type of haemor-
rhage was found in several patients, with other bleeding
manifestations occurring at similar rates to the current study in
children and adults.17,20 Thrombocytopenia was the major non-
speciﬁc laboratory ﬁnding that was used in the assessment of
leakage and bleeding in the current study, as also assessed by other
investigators.18,21 Furthermore, 21.5% of adults and 19.4% of
children were given blood products or fresh frozen plasma to
minimize leakage and bleeding, and mortality rates of 0.5% and 1%
were noted in children and adults, respectively, in the current
study.
Out of 1085 cases, 24 were screened for dengue IgM/IgG
antibodies by rapid assays. There were no speciﬁc criteria applied
with regard to the selection of patients for testing. Only those
patients who could afford the cost of the assay in private sector
laboratories had testing for dengue IgM/IgG antibodies. As this was
the ﬁrst large outbreak in Jaffna District, the health authorities
were not prepared in terms of laboratory diagnosis. The dengue
IgM/IgG positive rates (18/24) indicate the accuracy of the clinical
diagnosis to be approximately 75%. The lack of laboratory diagnosis
is a serious issue in Jaffna District. The clinical diagnosis might be
accurate when done by an experienced clinician, but we have no
laboratory-speciﬁc data to support the clinical diagnosis. Consid-
ering that DF/DHF is endemic in Sri Lanka and that there is a
prevalence of dengue vectors on the island, clinical suspicion might
be sufﬁcient to support the majority of DF/DHF case diagnoses
during an outbreak.21 On the other hand, the lack of laboratory
diagnostic methods to conﬁrm the clinical suspicion might affect
the prompt management of patients and the management of the
complications of DF. Early laboratory diagnosis would be useful, as
DF/DHF may be clinically similar to other bacterial and viral
infections.22 Equally, in a country with several other infections like
typhoid, typhus, leptospirosis, and chikungunya, laboratory
conﬁrmation will help to assess the DF/DHF burden to take
measures to manage and control DF/DHF.
Notiﬁcation of DF/DHF to the Health Epidemiology Unit is
mandatory, however more than half of the DF/DHF cases were not
K. Murugananthan et al. / International Journal of Infectious Diseases 27 (2014) 32–3636notiﬁed based on the ﬁndings of the present study. In the absence
of a speciﬁc treatment or vaccine, vector control is the only method
for the prevention and control of DF/DHF and vector control can be
accelerated by the authorities through proper notiﬁcation. Thus
the JTH authorities should take necessary action to ensure proper
DF/DHF notiﬁcation to the Epidemiology Unit, Ministry of Health,
Sri Lanka.
In conclusion, the suspected DF/DHF cases clearly showed a
seasonal variation in the distribution of cases. Females were more
affected than males by DF/DHF in Jaffna in the 2009/2010 outbreak.
Most of the clinical features observed were in agreement with the
clinical ﬁndings described by others, but vomiting was an
important feature observed at a high frequency in the current
study. The absence of laboratory diagnosis was the major
drawback noted in this study, and most of the cases were admitted
almost a week after the onset of symptoms. The delays in hospital
admission show the inadequate knowledge of the public on DF/
DHF and probably the poor level of clinical suspicion of the primary
contact doctors in the peripheral hospitals. Hence, proper training
of primary contact doctors on the clinical diagnosis of DF/DHF
would allow patients to attend early medical assessment at a larger
hospital like JTH for admission and proper monitoring in order to
prevent progression to the complications of DF/DHF. On the other
hand, increasing the availability of prompt virological and
antibody based diagnostic tests in the state sector laboratories
in the area would help to conﬁrm the clinical suspicion, leading to
more rapid hospital care for patients who might be prone to the
complications of DF/DHF. Moreover, educating the public on
dengue warning signs and emphasizing the importance of seeking
medical help promptly would also contribute to the prevention of
the complications of DF/DHF.
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